
Alcon Inc.
ALC
Updated: 24/09/2026, 07:31:16
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
No summaries found.
- Share price
- $65.39
- Market cap
- $31.89B
- Exchange
- NYSE
- Currency
- USD
- CEO
- David J. Endicott
- Employees
- 25,000
- IPO date
- 09/04/2019
- Beta
- 0.698
- Last dividend
- $0.00
- Day range
- $65.06 – $65.71
- 52-week range
- $61.84 – $87.64
- 1-day performance
- -0.30%
- 1-year performance
- 5.75%
- Current drawdown (1Y)
- -25.39%
- CIK
- 0001167379
- CUSIP
- H01301128
- ISIN
- CH0432492467
- Created
- 07/12/2025, 02:01:24
- Last update
- 24/09/2026, 07:31:16
Track Alcon Inc. with an AI analyst
See which prediction-market events move ALC, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Mexican Gold Announces Subscription Receipt Financing and Loan to Alcon Silver in Connection with Arrangement
Newsfile Corp • STOCK • 15/06/2026, 09:00:00
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued
GuruFocus • STOCK • 04/06/2026, 19:53:00
Alcon: Product Cycle Reset Creates An Attractive Entry Point (Initiating Buy)
Seeking Alpha • STOCK • 31/05/2026, 08:11:04
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Zacks Investment Research • STOCK • 28/05/2026, 13:06:10
Here's Why Alcon (ALC) is a Strong Value Stock
Zacks Investment Research • STOCK • 07/05/2026, 12:40:41
Algoma Central Corporation Reports Financial Results for the 2026 First Quarter
Business Wire • STOCK • 07/05/2026, 11:08:00
Alcon Inc. (ALC) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 07/05/2026, 09:39:18
Alcon (NYSE: ALC) Faces Stock Drop Despite Strong Q1 Earnings and New Product Success
Market Data • Market Data • 06/05/2026, 22:16:03
Swiss eye care firm Alcon's quarterly revenue rises, driven by product launches
Reuters • STOCK • 06/05/2026, 03:08:16
ALC vs. PEN: Which Stock Should Value Investors Buy Now?
Zacks Investment Research • STOCK • 05/05/2026, 14:41:09
Alcon Announces Results of 2026 Annual General Meeting
Business Wire • STOCK • 30/04/2026, 18:30:00
Are Medical Stocks Lagging Alcon (ALC) This Year?
Zacks Investment Research • STOCK • 14/04/2026, 12:41:00